Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma: Real World Evidence from the French Early Access Program

Affiliation auteurs!!!! Error affiliation !!!!
TitreSuperiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma: Real World Evidence from the French Early Access Program
Type de publicationJournal Article
Year of Publication2018
AuteursManson G, Mear J-B, Herbaux C, de Collela JMarc Schia, Casasnovas R-O, Stamatoullas A, Deau-Fisher B, Schmitt A, Garnier G, Molina L, Bouabdallah K, Moles M-P, Ghesquieres H, Tempescul A, Dulery R, Nicolas-Virelizier E, Delmer AJacques, Borel C, Chauchet A, Dercle L, Brice P, Houot R
JournalBLOOD
Volume132
Date PublishedNOV 29
Type of ArticleMeeting Abstract
ISSN0006-4971
DOI10.1182/blood-2018-99-110960